Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PostbiotiX is an Italian biotechnology company focused on the research and development of postbiotics, which are functional bioactive compounds generated during microbial fermentation. A spin-off from the University of Siena, the company utilizes a proprietary platform to identify and characterize specific bacterial strains and their metabolites to create targeted health solutions. Their product portfolio aims to modulate the gut microbiota to address gastrointestinal, inflammatory, and metabolic conditions. PostbiotiX provides both raw materials for the nutraceutical industry and finished formulations designed to improve human wellbeing through microbiome science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PostbiotiX.com.